Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection

The journey to a respiratory syncytial virus vaccine

(2020) Asuncion Mejias et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice

(2019) Megan E. Schmidt et al.   JOURNAL OF IMMUNOLOGY

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children

(2018) Elizabeth J McFarland et al.   JOURNAL OF INFECTIOUS DISEASES

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

(2018) Natalie I Mazur et al.   LANCET INFECTIOUS DISEASES

Respiratory Syncytial Virus Seasonality — United States, 2014–2017

(2018) Erica Billig Rose et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants

(2013) James F. Papin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age

(2013) Elissa Malkin et al.   PLoS One

The Human Respiratory Syncytial Virus Matrix Protein Is Required for Maturation of Viral Filaments

(2012) Ruchira Mitra et al.   JOURNAL OF VIROLOGY

Increasing the Time of Exposure to Aerosol Measles Vaccine Elicits an Immune Response Equivalent to That Seen in 9-Month-Old Mexican Children Given the Same Dose Subcutaneously

(2011) Rosa María Wong-Chew et al.   JOURNAL OF INFECTIOUS DISEASES

Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis

(2007) Nicola Low et al.   VACCINE